By 2025, gene editing technology, particularly CRISPR, stands at the precipice of profound social transformation in the US, raising critical ethical debates concerning equity, accessibility, human enhancement, and the very definition of disease. As we navigate the mid-2020s, the rapid advancements in gene editing technology, particularly CRISPR-Cas9, are not merely scientific milestones; they are catalysts […]